Vacunación frente a la neumonía adquirida en la comunidad del adultoposicionamiento del Grupo de Neumoexpertos en Prevención

  1. E. Redondo 6
  2. I. Rivero 7
  3. D.A. Vargas 8
  4. E. Mascarós 9
  5. J.L. Díaz-Maroto 10
  6. M. Linares 11
  7. J. Valdepérez 1
  8. A. Gil 2
  9. J. Molina 3
  10. I. Jimeno 4
  11. D. Ocaña 5
  12. F. Martinón-Torres 7
  1. 1 Centro de Salud Actur Sur, Zaragoza, España
  2. 2 Universidad Rey Juan Carlos, Madrid, España
  3. 3 Centro de Atención Primaria Francia, Fuenlabrada, Madrid, España
  4. 4 Centro de Salud Isla de Oza, Madrid, España
  5. 5 Centro de Salud Algeciras Norte, Algeciras, Cádiz, España
  6. 6 Centro de Salud Internacional Madrid Salud, Ayuntamiento de Madrid, Madrid, España
  7. 7 Complexo Hospitalario Universitario de Santiago
    info

    Complexo Hospitalario Universitario de Santiago

    Santiago de Compostela, España

    ROR https://ror.org/00mpdg388

  8. 8 Hospital de Alta Resolución El Toyo, Agencia Pública Sanitaria, Hospital de Poniente, Almería, España
  9. 9 Centro de Atención Primaria Fuente de San Luís, Valencia, España
  10. 10 Centro de Atención Primaria de Guadalajara, Guadalajara, España
  11. 11 Fundación io, Madrid, España
Show affiliations +
Journal:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Year of publication: 2016

Issue: 7

Pages: 464-475

Type: Article

DOI: 10.1016/J.SEMERG.2016.07.009 DIALNET GOOGLE SCHOLAR

More publications in: Semergen: revista española de medicina de familia

Abstract

Introduction Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in adults. The annual incidence of CAP in adults in Spain ranges from 3 to 14 cases per 1,000 inhabitants. Current clinical guidelines primarily focus on the therapeutic approach to CAP rather than its prevention. The aim of this study is to develop and propose a practical guide for CAP prevention through vaccination in Spain according to available vaccines and evidence. Methods A literature review and expert opinion. Results Pneumococcal and influenza vaccines are the main preventive tools available against CAP. Age, chronic diseases, and immunosuppression are risk factors for pneumonia, so these populations should be a priority for vaccination. In addition, influenza and pneumococcal vaccination is considered advisable in healthy adults under 60 years of age, and anyone with risk condition for CAP, irrespective of age. The influenza vaccine will be administered seasonally, while pneumococcal vaccination can be administered at any time of the year. Conclusions Vaccination against pneumococcus and influenza in adults can help to reduce the burden of CAP and its associated complications. The available evidence supports the priority indications set out in this guide, and it would be advisable to try to achieve a wide circulation and practical implementation of these recommendations.

Data source: Dialnet